Tag: Prevention

Learning from Lives and Deaths

People with a learning disability and autistic people (LeDeR)

Kings College London

The national Learning from Lives and Deaths – people with a learning disability and autistic people (LeDeR) report (2023) has been re-published in January 2026.

The Learning from Lives and Deaths – people with a learning disability and autistic people (LeDeR) programme, funded by NHS England and NHS Improvement, was established in 2017 to improve healthcare for people with a learning disability and autistic people. LeDeR aims to:

  • Improve care for people with a learning disability and autistic people.
  • Reduce health inequalities for people with a learning disability and autistic people.
  • Prevent people with a learning disability and autistic people from early deaths.

Access the report here: Learning from Lives and Deaths – people with a learning disability and autistic people (LeDeR) | King’s College London

Alcohol and drug misuse prevention, treatment and recovery guidance

Office for Health Improvement and Disparities (OHID); 2025.

Information and other resources to support commissioners, service providers and others providing alcohol and drug interventions. ‘Co-occurring mental health and substance use: delivery framework’ also added.

Alcohol and drug misuse prevention, treatment and recovery guidance – GOV.UK



Impact of young people’s admissions to adult mental health wards in England: national qualitative study

National policy in England recommends that young people be admitted to mental health wards that are age-appropriate. Despite this, young people continue to be admitted to adult wards. Our findings emphasise the importance of young people being admitted to age-appropriate in-patient facilities. Earlier intervention and increased provision of specialist care in the community could prevent young people’s admissions to adult wards.

Impact of young people’s admissions to adult mental health wards in England: national qualitative study | BJPsych Open | Cambridge Core

Is CBD the future of antipsychotic drugs? A new global study investigates

The Wellcome Trust is funding a new study and clinical trial that will further investigate the effectiveness of cannabidiol (CBD) in treating people with psychosis. Work carried out by Oxford University and King’s College London will look at whether CBD can be used not only to treat established psychosis, but also to prevent the onset of psychosis in people at high risk of developing it.

Is CBD the future of antipsychotic drugs? | News | Wellcome

Credit: Anastassiya Bezhekeneva
Licence: All Rights Reserved

A community-powered NHS

Making prevention a reality

Source: The King’s Fund

This report finds that by moving towards community-powered health –working collaboratively with communities as equal partners in the design and delivery of health care – can help make prevention a reality, protect the NHS’s future and improve health for all.

Report

Prevention in the age of information: public education for better health

This report highlights that tackling preventable illness must remain a top priority for the government in the 2020s. More than half of the disease burden in England is deemed preventable, with one in five deaths attributed to causes that could have been avoided. It goes on to argue that any prevention strategy must take into account the way information can be used to promote public health and spread information.